Zheng outlined how the firm has evolved from early machine-vision projects into what it now calls physical AI designed for ...

The pharmaceutical and biopharmaceutical industry needs to execute a shift from large-volume, single-product processes to small-volume, multiproduct processes. The shift is not restricted to ...